Rancho Santa Fe, CA, United States of America

David Shapiro

USPTO Granted Patents = 4 

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Location History:

  • Rancho Sante Fe, CA (US) (2018 - 2020)
  • Rancho Santa Fe, CA (US) (2020)

Company Filing History:


Years Active: 2018-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: David Shapiro: Innovator in Pharmaceutical Formulations

Introduction

David Shapiro is a notable inventor based in Rancho Santa Fe, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations involving obeticholic acid. With a total of 4 patents to his name, Shapiro's work has the potential to impact the treatment of various diseases and conditions.

Latest Patents

Among his latest patents, Shapiro has focused on "Compositions of obeticholic acid and methods of use." This disclosure relates to obeticholic acid formulations that exhibit improved stability, dissolution, and solubility. The methods outlined in his patents detail the preparation of these formulations for therapeutic use, showcasing their potential in treating a range of medical conditions.

Career Highlights

David Shapiro is currently associated with Intercept Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in drug formulation has positioned him as a key player in the industry, contributing to advancements that may enhance patient care.

Collaborations

Shapiro has collaborated with notable colleagues, including Richard Gail Lancaster and Kay Olmstead. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical field.

Conclusion

David Shapiro's work in pharmaceutical formulations, particularly with obeticholic acid, highlights his commitment to advancing medical treatments. His contributions through patents and collaborations reflect a dedication to improving health outcomes for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…